ARTHEMIR Trademark

Trademark Overview


On Friday, January 13, 2023, a trademark application was filed for ARTHEMIR with the United States Patent and Trademark Office. The USPTO has given the ARTHEMIR trademark a serial number of 79364718. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Arthex Biotech S.L.. The ARTHEMIR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the treatment of progressive muscle wasting disease; injectable pharmaceutical products for the treatment of progressive muscle wasting disease; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of progressive muscle wasting disease

Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials in the nature of tests for others; clinical studies for pharmaceutical products; conducting clinical trials for pharmaceutical products; scientific and medical information regarding pharmaceutical products and clinical trials; provision of information regarding results of clinical trials relating to pharmaceutical products
arthemir

General Information


Serial Number79364718
Word MarkARTHEMIR
Filing DateFriday, January 13, 2023
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7349646
Registration DateTuesday, April 9, 2024
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements


Description of MarkThe mark consists of "ARTHEMIR" in stylized font with the first and last letter capitalized.
Goods and ServicesPharmaceutical products for the treatment of progressive muscle wasting disease; injectable pharmaceutical products for the treatment of progressive muscle wasting disease; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of progressive muscle wasting disease
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials in the nature of tests for others; clinical studies for pharmaceutical products; conducting clinical trials for pharmaceutical products; scientific and medical information regarding pharmaceutical products and clinical trials; provision of information regarding results of clinical trials relating to pharmaceutical products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 10, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameArthex Biotech S.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES

Party NameArthex Biotech S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES

Party NameArthex Biotech S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events


Event DateEvent Description
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Monday, January 22, 2024NOTIFICATION PROCESSED BY IB
Wednesday, January 3, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 3, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 13, 2023REFUSAL PROCESSED BY IB
Tuesday, October 24, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, October 24, 2023REFUSAL PROCESSED BY MPU
Saturday, October 14, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 13, 2023NON-FINAL ACTION WRITTEN
Wednesday, October 11, 2023ASSIGNED TO EXAMINER
Tuesday, March 14, 2023APPLICATION FILING RECEIPT MAILED
Friday, March 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 9, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB